Finerenone (BAY 94-8862)

DRUG6 trials

Conditions

AlbuminuriaCardiovascular DiseasesChronic Kidney DiseaseChronic Kidney Disease Due to Type 2 Diabetes MellitusChronic Kidney Disease(CKD)Chronic Kidney DiseasesNephrectomyRenal Cell Carcinoma (Kidney Cancer)

Phase 2

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

TerminatedNCT06818305

Jinling Hospital, ChinaChronic Kidney Disease(CKD), Nephrectomy, Renal Cell Carcinoma (Kidney Cancer) +1

Start: 2025-01-01End: 2025-10-01Updated: 2025-12-11

Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide

CompletedNCT07819227

University Medical Center GroningenChronic Kidney Disease

Start: 2025-02-11End: 2026-08-31Updated: 2026-09-14

Phase 3

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Enrolling by invitationNCT07181135

University Medical Center GroningenChronic Kidney Disease

Start: 2026-03-13End: 2027-12-31Target: 180Updated: 2026-04-14

Phase 4

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

RecruitingNCT07026539

University of AarhusCardiovascular Diseases, Chronic Kidney Disease Due to Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM)

Start: 2024-10-23End: 2028-04-30Target: 80Updated: 2025-06-24

Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

Not yet recruitingNCT07667517

First Affiliated Hospital of Zhejiang UniversityAlbuminuria, Chronic Kidney Diseases, Type 2 Diabetes Mellitus (T2DM)

Start: 2026-07-01End: 2027-12-31Target: 148Updated: 2026-06-25

Unknown Phase

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

RecruitingNCT06278207

BayerChronic Kidney Disease, Type 2 Diabetes Mellitus

Start: 2024-05-15End: 2026-09-30Target: 50000Updated: 2026-06-18

Related Papers

Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform

Journal of Clinical Medicine2024-08-2812 citations